Reviva Pharmaceuticals Holdings, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Reviva Pharmaceuticals Holdings, Inc. (RVPH) had Deferred Tax Assets, Operating Loss Carryforwards of $18.97 million as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-30
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $18.97M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $15.69M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $15.26M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $12.70M; Deferred Tax Assets, Operating Loss Carryforwards as first filed $12.62M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $18.97M 10-K · filed 2026-03-30 | |
| 2024-12-31 | $15.69M 10-K · filed 2026-03-30 | |
| 2023-12-31 | $15.26M 10-K · filed 2025-04-03 | |
| 2022-12-31 | $12.70M 10-K · filed 2024-04-15 | $12.62M 10-K · filed 2023-03-30 |
| 2021-12-31 | $11.26M 10-K · filed 2023-03-30 | |
| 2020-12-31 | $9.18M 10-K · filed 2022-03-15 | |
| 2019-12-31 | $8.71M 10-K/A · filed 2021-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |